Information  X 
Enter a valid email address

Antisoma plc (SRC)

  Print      Mail a friend       Annual reports

Thursday 18 October, 2007

Antisoma plc

Holdings in Antisoma

London, UK: 18 October 2007 - Antisoma plc (LSE: ASM, US OTC: ATSMY)
received notification on 17 October from Orbimed Advisors LLC that,
following a disposal of ordinary shares, Caduceus Capital Master Fund
Ltd.; Caduceus Capital II, LP; UBS Eucalyptus Fund, LLC; PW
Eucalyptus Fund, Ltd.; and Summer Street Life Sciences Hedge Fund
Investors LLC have reduced their direct interest in ordinary 1p
shares from 14,717,955 to 3,917,955, resulting in a holding
representing approximately 0.88% of Antisoma's issued ordinary

                              - END -

Daniel Elger, Director of Communications
Antisoma plc
+44 (0) 20 8799 8200